Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Disease Exacerbation

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, M; Innis, RB; Kugaya, A1
Barthel, H; Dietrich, J; Georgi, P; Hermann, W; Reuter, M; Wagner, A1

Reviews

1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Disease Exacerbation

ArticleYear
Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.
    Annals of nuclear medicine, 2000, Volume: 14, Issue:1

    Topics: Animals; Benzamides; Brain; Carrier Proteins; Cocaine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon

2000

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Disease Exacerbation

ArticleYear
[Hallervorden-Spatz disease: findings in the nigrostriatal system].
    Der Nervenarzt, 2000, Volume: 71, Issue:8

    Topics: Adolescent; Benzamides; Cocaine; Corpus Striatum; Diagnosis, Differential; Disease Progression; Dopamine Antagonists; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinsonian Disorders; Pyrrolidines; Substantia Nigra; Tomography, Emission-Computed, Single-Photon

2000